Duke BioRepository & Precision Pathology Center
Duke BioRepository & Precision Pathology Center specializes in advanced diagnostics and comprehensive cancer treatment, focusing on breast, gynecological, and brain cancers, and utilizes precision medicine to tailor treatments.
Services
Duke BioRepository & Precision Pathology Center offers advanced diagnostics, genetic and prevention counseling, and a full scope of treatments for early, advanced-stage, metastatic, and rare forms of breast cancer. The center provides comprehensive cancer treatment options, including precision medicine approaches to optimize and tailor treatments while minimizing risks. Additionally, the center offers cancer support and survivorship services, aiming to improve health outcomes through high-quality services.
Participation in Pediatric Neurology Consortia
The center participates in the Pacific Pediatric Neurology Consortium (PNOC) and the COllaborative NEtwork for Neuro-oncology Clinical Trials (CONNECT). These collaborations aim to develop new therapies and improve outcomes for children and young adults with brain tumors. By engaging in these consortia, the center contributes to advancing the understanding and treatment of pediatric neurological conditions.
Research in Gynecological Cancers
Duke BioRepository & Precision Pathology Center conducts comprehensive research to understand, detect, treat, and improve outcomes for people with gynecological cancers. The center engages in various research activities to advance the detection and treatment of these cancers, striving to enhance patient experiences and optimize outcomes.
Precision Medicine and Biomarkers
The center utilizes precision medicine to examine patient biomarkers, including urine or blood-based biomarkers, tissue-based biomarkers, and imaging biomarkers. This approach helps in optimizing and tailoring patient treatments while minimizing associated risks. Through precision medicine, the center aims to provide personalized and effective treatment plans for cancer patients.
Development of Immunotherapies
Duke BioRepository & Precision Pathology Center focuses on the development of new immunotherapies, including new indications and combinations of drugs that involve immunotherapies. The center's dedication to immunotherapy research aims to enhance treatment options and improve outcomes for cancer patients. This work contributes to the broader effort of finding more effective cancer treatments.